2254. Multicenter Evaluation of Ceftazidime–Avibactam for Multidrug-Resistant Pseudomonas aeruginosa Infections

BACKGROUND: Ceftazidime–avibactam (CZA) is a novel cephalosporin/β-lactamase inhibitor with activity against carbapenem-resistant Enterobacteriaceae (CRE) and multidrug-resistant (MDR) Pseudomonas aeruginosa (PA). Real-world experience with CZA for CRE infections is accumulating but data on its use...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Open Forum Infect Dis
Main Authors: Jorgensen, Sarah C J, Trinh, Trang D, Zasowski, Evan J, Alosaimy, Sara, Lagnf, Abdalhamid M, Bhatia, Sahil, Melvin, Sarah, Simon, Samuel, Steed, Molly E, Rosenberg, Joshua R, Estrada, Sandra J, Davis, Susan L, Rybak, Michael J
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2019
Teme:
Abstracts
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6809679/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.1932
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki